Form 8-K - Current report:
SEC Accession No. 0001193125-17-217588
Filing Date
2017-06-29
Accepted
2017-06-29 09:31:33
Documents
3
Period of Report
2017-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d419252d8k.htm 8-K 24326
2 EX-99.1 d419252dex991.htm EX-99.1 20636
3 EX-99.2 d419252dex992.htm EX-99.2 63137
  Complete submission text file 0001193125-17-217588.txt   109517
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 17936935
SIC: 2834 Pharmaceutical Preparations